Literature DB >> 10597726

Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.

A Pollack1, G K Zagars, I I Rosen.   

Abstract

Technological advances in treatment delivery and planning have provided the backdrop for an unprecedented number of options in the treatment of prostate cancer with radiotherapy. The more common choices include classical external-beam radiotherapy, external-beam radiotherapy using three-dimensional treatment planning and conformal radiotherapy (3DCRT), ultrasound-guided transperineal implant monotherapy alone or in combination with external-beam radiotherapy, and intensity-modulated radiotherapy (IMRT) techniques. This chapter reviews the data from these methods with an emphasis on dose escalation, provides comparisons with prostate-specific antigen (PSA)-era radical prostatectomy series where appropriate, and highlights future initiatives designed to further improve outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597726

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  5 in total

Review 1.  Prostate cancer.

Authors:  D Mazhar; J Waxman
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

2.  Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol.

Authors:  Yoshiki Norihisa; Takashi Mizowaki; Kenji Takayama; Yuki Miyabe; Kiyotomo Matsugi; Yukinori Matsuo; Masaru Narabayashi; Katsuyuki Sakanaka; Akira Nakamura; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2011-09-29       Impact factor: 3.402

3.  Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Authors:  Simon M Collin; Richard M Martin; Chris Metcalfe; David Gunnell; Peter C Albertsen; David Neal; Freddie Hamdy; Peter Stephens; J Athene Lane; Rollo Moore; Jenny Donovan
Journal:  Lancet Oncol       Date:  2008-04-16       Impact factor: 41.316

4.  Molecular targets for radiation oncology in prostate cancer.

Authors:  Tao Wang; Lucia R Languino; Jane Lian; Gary Stein; Michael Blute; Thomas J Fitzgerald
Journal:  Front Oncol       Date:  2011-07-13       Impact factor: 6.244

Review 5.  Treatments for improving survival of patients with prostate cancer.

Authors:  Alice K David; Radhika Khwaja; Gary R Hudes
Journal:  Drugs Aging       Date:  2003       Impact factor: 4.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.